Pathology, Radiation therapy, Internal medicine, Oncology and Carcinoma are her primary areas of study. Her research integrates issues of Cancer research, Hypoxia and microRNA in her study of Pathology. The study incorporates disciplines such as Prostate cancer and Chemotherapy in addition to Radiation therapy.
Her Internal medicine study combines topics from a wide range of disciplines, such as PI3K/AKT/mTOR pathway, PTEN and Kinase. Her Oncology study combines topics in areas such as Stage, Breast cancer, Carbogen and Head and neck. Her Carcinoma research includes elements of Dynamic contrast-enhanced MRI, Metastasis, T1 weighted and Cervix.
The scientist’s investigation covers issues in Internal medicine, Oncology, Radiation therapy, Pathology and Cancer research. Her research in Oncology tackles topics such as Genome-wide association study which are related to areas like Genetic association. The concepts of her Radiation therapy study are interwoven with issues in Breast cancer and Carcinoma.
Her Carcinoma study integrates concerns from other disciplines, such as Radiology, Nuclear medicine, Cancer staging and Cervix. Her research ties Adenocarcinoma and Pathology together. Her Cancer research research is multidisciplinary, incorporating elements of Cancer cell, Endocrinology, Gene and Immunology.
Her primary areas of study are Internal medicine, Oncology, Radiation therapy, Prostate cancer and Hypoxia. Her biological study spans a wide range of topics, including Cancer, Breast cancer, Head and neck cancer and Proportional hazards model. Her research in Cancer intersects with topics in Multivariate analysis and Nomogram.
Her Radiation therapy study incorporates themes from Bladder cancer, Gene signature, Medical physics and Cohort study. She interconnects Relative risk, Genome-wide association study, Single-nucleotide polymorphism and Case-control study in the investigation of issues within Prostate cancer. Her Hypoxia research includes themes of Soft tissue sarcoma, Cancer research, Transcriptome and Bioinformatics.
Catharine M L West mostly deals with Internal medicine, Oncology, Prostate cancer, Radiation therapy and Hypoxia. Her research investigates the connection between Oncology and topics such as Metastasis that intersect with problems in Tumour heterogeneity, Sarcoma, Tissue microarray and Pathology. Her Prostate cancer research is multidisciplinary, relying on both Genetic model, Breast cancer, Genome-wide association study and Genotype.
She has included themes like Bladder cancer, Absolute risk reduction, Cohort study, Gene signature and Prospective cohort study in her Radiation therapy study. Her Hypoxia research incorporates themes from Biomarker, Transcriptome and Bioinformatics. Catharine M L West combines subjects such as Magnetic resonance imaging, Renal cell carcinoma, Perfusion and Carcinoma with her study of Tumor hypoxia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study.
Gillian C. Barnett;Gillian C. Barnett;Charlotte E. Coles;Rebecca M. Elliott;Caroline Baynes.
Lancet Oncology (2012)
Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix.
Juliette A. Loncaster;Adrian L. Harris;Susan E. Davidson;John P. Logue.
Cancer Research (2001)
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Fredrick R. Schumacher;Ali Amin Al Olama;Sonja I. Berndt;Sara Benlloch.
Nature Genetics (2018)
Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix.
R Airley;Juliette A Loncaster;Susan E Davidson;Michael Bromley.
Clinical Cancer Research (2001)
Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene.
F. M. Buffa;A.L. Harris;C. M. West;Crispin Miller.
British Journal of Cancer (2010)
Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers.
Stuart C Winter;Francesca M Buffa;Priyamal Silva;Crispin J Miller.
Cancer Research (2007)
Head and neck cancer—Part 1: Epidemiology, presentation, and prevention
H Mehanna;V Paleri;C M L West;C Nutting.
The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis.
H E Gee;F M Buffa;C Camps;A Ramachandran.
British Journal of Cancer (2011)
Imaging tumour hypoxia with positron emission tomography.
Ian N Fleming;Roido Manavaki;Philip J Blower;Catharine West.
British Journal of Cancer (2015)
GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding.
Rachel E. Airley;Juliette Loncaster;James A. Raleigh;Adrian L. Harris.
International Journal of Cancer (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: